Literature DB >> 24004341

Bioenergetic medicine.

Russell H Swerdlow1.   

Abstract

Here we discuss a specific therapeutic strategy we call 'bioenergetic medicine'. Bioenergetic medicine refers to the manipulation of bioenergetic fluxes to positively affect health. Bioenergetic medicine approaches rely heavily on the law of mass action, and impact systems that monitor and respond to the manipulated flux. Since classically defined energy metabolism pathways intersect and intertwine, targeting one flux also tends to change other fluxes, which complicates treatment design. Such indirect effects, fortunately, are to some extent predictable, and from a therapeutic perspective may also be desirable. Bioenergetic medicine-based interventions already exist for some diseases, and because bioenergetic medicine interventions are presently feasible, new approaches to treat certain conditions, including some neurodegenerative conditions and cancers, are beginning to transition from the laboratory to the clinic.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  Alzheimer's disease; cancer; glycolysis; law of mass action; mitochondria; neurodegeneration

Mesh:

Year:  2014        PMID: 24004341      PMCID: PMC3976609          DOI: 10.1111/bph.12394

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  188 in total

Review 1.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 2.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

3.  Age, sex and laterality effects on cerebral glucose metabolism in healthy adults.

Authors:  Mark W Willis; Terence A Ketter; Tim A Kimbrell; Mark S George; Peter Herscovitch; Aimee L Danielson; Brenda E Benson; Robert M Post
Journal:  Psychiatry Res       Date:  2002-02-15       Impact factor: 3.222

4.  Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.

Authors:  K Ranga Rama Krishnan; H Cecil Charles; P Murali Doraiswamy; Jacobo Mintzer; Richard Weisler; Xin Yu; Carlos Perdomo; John R Ieni; Sharon Rogers
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

5.  Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Authors:  Paul H Gordon; Dan H Moore; Robert G Miller; Julaine M Florence; Joseph L Verheijde; Carolyn Doorish; Joan F Hilton; G Mark Spitalny; Robert B MacArthur; Hiroshi Mitsumoto; Hans E Neville; Kevin Boylan; Tahseen Mozaffar; Jerry M Belsh; John Ravits; Richard S Bedlack; Michael C Graves; Leo F McCluskey; Richard J Barohn; Rup Tandan
Journal:  Lancet Neurol       Date:  2007-11-05       Impact factor: 44.182

6.  PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders.

Authors:  Sarika Srivastava; Francisca Diaz; Luisa Iommarini; Karine Aure; Anne Lombes; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2009-03-18       Impact factor: 6.150

7.  Glycolysis-respiration relationships in a neuroblastoma cell line.

Authors:  Russell H Swerdlow; Lezi E; Daniel Aires; Jianghua Lu
Journal:  Biochim Biophys Acta       Date:  2013-01-10

8.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

Review 9.  Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.

Authors:  Jean-Paul Bonnefont; Fatima Djouadi; Carina Prip-Buus; Stephanie Gobin; Arnold Munnich; Jean Bastin
Journal:  Mol Aspects Med       Date:  2004 Oct-Dec

Review 10.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

View more
  24 in total

Review 1.  Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.

Authors:  Heather M Wilkins; Russell H Swerdlow
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

2.  Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis.

Authors:  Heather M Wilkins; Janna L Harris; Steven M Carl; Lezi E; Jianghua Lu; J Eva Selfridge; Nairita Roy; Lewis Hutfles; Scott Koppel; Jill Morris; Jeffrey M Burns; Mary L Michaelis; Elias K Michaelis; William M Brooks; Russell H Swerdlow
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

3.  Measurement of Mitochondrial Respiration in Platelets.

Authors:  Zdeněk Fišar; Jana Hroudová
Journal:  Methods Mol Biol       Date:  2021

4.  A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.

Authors:  Heather M Wilkins; Jonathan D Mahnken; Paul Welch; Rebecca Bothwell; Scott Koppel; Richard L Jackson; Jeffrey M Burns; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.

Authors:  Judit M Perez Ortiz; Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

6.  Mitochondrial pharmacology: energy, injury and beyond.

Authors:  S M Davidson; G D Lopaschuk; M Spedding; P M Beart
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 7.  Bioenergetics and metabolism: a bench to bedside perspective.

Authors:  Russell H Swerdlow
Journal:  J Neurochem       Date:  2016-03-10       Impact factor: 5.372

Review 8.  Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities.

Authors:  Charles C Caldwell; Jia Yao; Roberta Diaz Brinton
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

9.  A bioenergetics systems evaluation of ketogenic diet liver effects.

Authors:  Lewis J Hutfles; Heather M Wilkins; Scott J Koppel; Ian W Weidling; J Eva Selfridge; Eephie Tan; John P Thyfault; Chad Slawson; Aron W Fenton; Hao Zhu; Russell H Swerdlow
Journal:  Appl Physiol Nutr Metab       Date:  2017-05-17       Impact factor: 2.665

10.  Lactate's effect on human neuroblastoma cell bioenergetic fluxes.

Authors:  Lezi E; Russell H Swerdlow
Journal:  Biochem Pharmacol       Date:  2015-11-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.